Experience of a novel community testing programme for COVID-19 in London: Lessons learnt
Experience of a novel community testing programme for COVID-19 in London: Lessons learnt
复制标题
DOI：
10.7861/clinmed.2020-0436
复制
发表时间：
2020-09-01
影响因子：
4.4
通讯作者：
Whittington, Ashley
中科院分区：
文献类型：
--
作者：
Wallis, Gabriel;Siracusa, Francesca;Whittington, Ashley
我们描述了为COVID-19开发的伦敦社区检测计划，审计其有效性，并根据对参与者进行的调查报告患者的可接受性和患者对隔离指导的遵守情况。任何符合英格兰公共卫生（PHE）COVID-19病例定义且不需要住院的患者都有资格接受社区检测。2020年1月至3月期间，在社区对2，053名疑似COVID-19患者进行了检测。其中75人（3.6%）呈阳性。完成患者调查的患者中有88%的人感到安全，82%的人认为社区检测比住院更可取。97%的人在隔离期间能够留在自己家中，但只有41%的人能够可靠地与其他家庭成员隔离。伦敦社区检测计划允许对COVID-19进行广泛检测，同时最大限度地减少患者运输、住院和员工暴露。社区检测对患者来说是可以接受的，比住院更可取。患者能够在家中可靠地隔离，但不能与家庭接触者隔离。作者认为，社区COVID-19检测作为缓解第二波感染的一揽子干预措施的一部分具有重要性、可行性和可接受性。
We describe the London community testing programme developed for COVID-19, audit its effectiveness and report patient acceptability and patient adherence to isolation guidance, based upon a survey conducted with participants. Any patients meeting the Public Health England (PHE) case definition for COVID-19 who did not require hospital admission were eligible for community testing. 2,053 patients with suspected COVID-19 were tested in the community between January and March 2020. Of those tested, 75 (3.6%) were positive. 88% of patients that completed a patient survey felt safe and 82% agreed that community testing was preferable to hospital admission. 97% were able to remain within their own home during the isolation period but just 41% were able to reliably isolate from other members of their household. The London community testing programme allowed widespread testing for COVID-19 while minimising patient transport, hospital admissions and staff exposures. Community testing was acceptable to patients and preferable to admission to hospital. Patients were able to reliably isolate in their home but not from household contacts. The authors believe in the importance, feasibility and acceptability of community testing for COVID-19 as a part of a package of interventions to mitigate a second wave of infection.